
Delafloxacin
CAS No. 189279-58-1
Delafloxacin ( RX-3341 | WQ-3034 | ABT492 )
产品货号. M17400 CAS No. 189279-58-1
Delafloxacin (RX-3341, ABT-492) 是一种氟喹诺酮类抗生素。它对左氧氟沙星耐药肺炎链球菌菌株具有有效的抑制作用(MIC:0.0078-0.125 μg/ml)。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
10MG | ¥316 | 有现货 |
![]() ![]() |
25MG | ¥648 | 有现货 |
![]() ![]() |
50MG | ¥1239 | 有现货 |
![]() ![]() |
100MG | ¥1968 | 有现货 |
![]() ![]() |
200MG | ¥2924 | 有现货 |
![]() ![]() |
500MG | ¥4763 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Delafloxacin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Delafloxacin (RX-3341, ABT-492) 是一种氟喹诺酮类抗生素。它对左氧氟沙星耐药肺炎链球菌菌株具有有效的抑制作用(MIC:0.0078-0.125 μg/ml)。
-
产品描述Delafloxacin (RX-3341, ABT-492) is a fluoroquinolone antibiotic agent. It has potent inhibitory against levofloxacin-resistant Streptococcus pneumoniae strains (MIC: 0.0078-0.125 μg/ml).
-
体外实验——
-
体内实验Delafloxacin (the total daily doses vary from 0.156 to 640 mg/kg/24 h, subcutaneous injection) is highly effective against S. aureus. Against all four strains are observed a decrease of 1.5 to 2.2 log10 CFU in organism burden from untreated controls at even the lowest dose studied, and for two strains (MW2 and R2527) there is net bactericidal activity at the lowest dose. At the maximal doses studied, there is a >4-log10 kill from initial burden for all S. aureus strains.Delafloxacin (2.5, 10, 40, and 160 mg/kg; subcutaneous injection, 24 h) has moderate terminal elimination half-life (t1/2=0.68 h, 0.79 h, 0.69 h and 1.0 h for 2.5 mg/kg, 10 mg/kg, 40 mg/kg, and 160 mg/kg, respectively). Animal Model:Mice with a neutropenic murine lung infection model (fourS. aureus , four S. pneumoniae, and fourK. pneumoniae strains)Dosage:The total daily doses vary from 0.156 to 640 mg/kg/24 h Administration: 0.03 to 160 mg/kg are administered every 6 h (q6h) to infected mice by subcutaneous injection Result:Inhibited S. aureus strains ATCC 29213, ATCC 33591, MW2, R2527 with MICs of 0.008, 0.008, 0.004, and 0.004 mg/L, respectively.Inhibited S. pneumoniae strains ATCC 10813, ATCC 49619, 145, and 1329 with MICs of 0.03, 0.125, 0.016, and 0.016 mg/L, respectively.Inhibited K. pneumonia strains ATCC 43816, 4105, 4110, and 81-1260A with MICs of 0.06, 1, 0.5, and 0.06 mg/L, respectively.Animal Model:Neutropenic mice Dosage:2.5, 10, 40, and 160 mg/kg; 0.2 mL Administration:Subcutaneous injection; 24 h Result:The maximum drug concentrations (Cmax) concentrations ranged from 2 to 71 mg/L. AUC0-∞ values ranged from 2.8 to 152 mg?h/L and were linear across the 2.5- to 160-mg dosing range. The elimination half-life (t1/2) ranged from 0.7 to 1 h.
-
同义词RX-3341 | WQ-3034 | ABT492
-
通路Wnt/Notch/Hedgehog
-
靶点Wnt/beta/catenin
-
受体Bacterial
-
研究领域Infection
-
适应症——
化学信息
-
CAS Number189279-58-1
-
分子量440.76
-
分子式C18H12ClF3N4O4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (226.88 mM)
-
SMILESC1C(CN1c1c(cc2c(c1Cl)n(cc(c2=O)C(=O)O)c1nc(c(cc1F)F)N)F)O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Gunderson SM, Hayes RA, Quinn JP, Antimicrob Agents Chemother. 2004 Jan;48(1):203-8.
产品手册




关联产品
-
Miclxin
Miclxin (DS37262926) 是突变体 β-catenin 的有效抑制剂,参与 Wnt 信号通路。Miclxin 可诱导 β-catenin 依赖性凋亡,导致线粒体损伤,线粒体膜丢失。Miclxin 通过靶向 MIC60 杀伤肿瘤,MIC60 是线粒体接触位点和嵴组织系统 (MICOS) 复合体的主要组成部分。
-
BML-284 HCL
BML-284 HCL 是一种有效的、选择性的 Wnt 经典信号传导激活剂和微管蛋白聚合抑制剂。BML-284 HCL 不会抑制 GSK-3β 的活性,可能是研究涉及 Wnt 途径的生理过程的有用工具。
-
WAY-328173
WAY-328173 是一种 Wnt/β-catenin 激动剂。